CYP19A1

Across TCGA pan-cancer cohorts, CYP19A1 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CYP19A1 data layer compared with 22 for mass-spec protein and 9 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CYP19A1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated CYP19A1 expression acts as an unfavorable survival marker.

UCEC are the cancer types where CYP19A1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.694	1.000	.015	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

CYP19A1–UCEC (OS)

Open the UCEC breakdown →